PureTech News

Press Releases
ALL >
Press Release - 2026-02-25
Other
PureTech to Present at the Leerink Partners Global Healthcare Conference
Continue
Press Release - 2026-02-19
Celea Therapeutics – Deupirfenidone (LYT-100)
PureTech Announces Orphan Drug Designations Granted by the U.S. Food and Drug Administration and European Commission for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis
Continue
Press Release - 2026-01-06
Other
PureTech to Present at 44th Annual J.P. Morgan Healthcare Conference
Continue
Publications
ALL >
Publications 2025-05-08
Perspectives of people living with idiopathic pulmonary fibrosis: a qualitative and quantitative study
Full Article
Publications 2025-02-11
Molecular Pharmaceutics: Optimizing Triglyceride Prodrugs of a Model Immunomodulator: Conjugation through the Phenol of Mycophenolic Acid (MPA) Markedly Promotes Lymphatic Drug Transport
Full Article
Publications 2024-03-04
Validating the efficacy and value proposition of mental fitness vocal biomarkers in a psychiatric population: prospective cohort study
Full Article

@PureTechH